26 Aug, 2009
FDA Issues Safety Concern on Liver Problems from Weight Loss Drug Orlistat
Posted by: Naturally In: Medical
The U.S. Food and Drug Administration announced today that it is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug Xenical and the over-the-counter medication Alli.
Between 1999 and 2008, the FDA received 32 reports of serious liver injury in patients taking orlistat. Of those [...]

Go Back


